Search

everythinglearnresearchcommunity

for

Search:↓

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride reduces pain in male rats and works better with testosterone.

Ro 10-9359 is an effective treatment for severe psoriasis but can cause side effects.

RXRa is crucial for Th2 immune cell development and may link nutrition to immune health.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Ruxolitinib can cause a delayed skin reaction on the nose.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.